DE602004026051D1 - Pharmazeutisch verträgliches verfahren zur reinigung intakter bakterienminizellen - Google Patents

Pharmazeutisch verträgliches verfahren zur reinigung intakter bakterienminizellen

Info

Publication number
DE602004026051D1
DE602004026051D1 DE602004026051T DE602004026051T DE602004026051D1 DE 602004026051 D1 DE602004026051 D1 DE 602004026051D1 DE 602004026051 T DE602004026051 T DE 602004026051T DE 602004026051 T DE602004026051 T DE 602004026051T DE 602004026051 D1 DE602004026051 D1 DE 602004026051D1
Authority
DE
Germany
Prior art keywords
minicells
provides
minimities
minicell preparations
purified minicell
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE602004026051T
Other languages
German (de)
English (en)
Inventor
Himanshu Brahmbhatt
Jennifer Macdiarmid
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
EnGeneIC Molecular Delivery Pty Ltd
Original Assignee
EnGeneIC Molecular Delivery Pty Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by EnGeneIC Molecular Delivery Pty Ltd filed Critical EnGeneIC Molecular Delivery Pty Ltd
Publication of DE602004026051D1 publication Critical patent/DE602004026051D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66Microorganisms or materials therefrom
    • A61K35/74Bacteria
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/02Separating microorganisms from their culture media
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20Bacteria; Culture media therefor

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
DE602004026051T 2003-06-24 2004-06-23 Pharmazeutisch verträgliches verfahren zur reinigung intakter bakterienminizellen Expired - Lifetime DE602004026051D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US10/602,021 US7611885B2 (en) 2003-06-24 2003-06-24 Pharmaceutically compatible method for purifying intact bacterial minicells
PCT/IB2004/002091 WO2004113507A1 (en) 2003-06-24 2004-06-23 Pharmaceutically compatible method for purifying intact bacterial minicells

Publications (1)

Publication Number Publication Date
DE602004026051D1 true DE602004026051D1 (de) 2010-04-29

Family

ID=33539477

Family Applications (1)

Application Number Title Priority Date Filing Date
DE602004026051T Expired - Lifetime DE602004026051D1 (de) 2003-06-24 2004-06-23 Pharmazeutisch verträgliches verfahren zur reinigung intakter bakterienminizellen

Country Status (19)

Country Link
US (4) US7611885B2 (da)
EP (3) EP1636344B1 (da)
JP (1) JP4834544B2 (da)
CN (2) CN1809629B (da)
AT (2) ATE513032T1 (da)
AU (2) AU2004249970B2 (da)
CA (2) CA2780843C (da)
CY (1) CY1118218T1 (da)
DE (1) DE602004026051D1 (da)
DK (3) DK2333044T3 (da)
ES (3) ES2602572T3 (da)
HK (3) HK1089207A1 (da)
HU (1) HUE030642T2 (da)
MX (1) MXPA05013620A (da)
NZ (1) NZ544653A (da)
PL (2) PL1947171T3 (da)
PT (2) PT2333044T (da)
SI (1) SI2333044T1 (da)
WO (1) WO2004113507A1 (da)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2380612T3 (es) * 2001-10-15 2012-05-16 Engeneic Molecular Delivery Pty Ltd. Minicélulas intactas como vectores para transferencia de ADN y terapia génica in vitro e in vivo
US7611885B2 (en) * 2003-06-24 2009-11-03 Engeneic Molecular Delivery Pty, Ltd. Pharmaceutically compatible method for purifying intact bacterial minicells
EP1694361B1 (en) 2003-12-09 2011-03-16 EnGeneIC Molecular Delivery Pty Ltd. Targeted gene delivery to non-phagocytic mammalian cells via bacterially derived intact minicells
US8772013B2 (en) * 2004-02-02 2014-07-08 Engeneic Molecular Delivery Pty Ltd Methods for targeted in vitro and in vivo drug delivery to mammalian cells via bacterially derived intact minicells
EP1718338B1 (en) 2004-02-02 2015-05-06 EnGeneIC Molecular Delivery Pty Ltd. Compositions and methods for targeted in vitro and in vivo drug delivery to mammalian cells via bacterially derived intact minicells
DK2386640T3 (da) 2004-08-26 2015-04-27 Engeneic Molecular Delivery Pty Ltd Afgivelse af funktionelle nukleinsyrer til pattedyrceller via bakterielt afledte, intakte miniceller
HUE033007T2 (en) 2006-06-23 2017-11-28 Engeneic Molecular Delivery Pty Ltd Targeted drug, therapeutic nucleic acid and functional nucleic acid delivery to mammalian cells via intact killed bacterial cells
PT2865755T (pt) 2007-03-30 2017-05-26 Engeneic Molecular Delivery Pty Ltd Minicélulas intactas derivadas de bactéria compreendendo arn regulatório
KR20180013993A (ko) 2008-06-25 2018-02-07 벡션 테라퓨틱스 엘엘씨 조절된 유전자 자살 메커니즘 조성물 및 방법
US8653236B2 (en) 2008-07-17 2014-02-18 Inter-K Pty Limited Therapeutic agents
WO2010129779A1 (en) 2009-05-07 2010-11-11 Biomerieux, Inc. Methods for antimicrobial resistance determination
US20120142089A1 (en) * 2010-12-01 2012-06-07 Samsung Electronics Co., Ltd. Method of separating target cell in biological sample
US9624474B2 (en) * 2010-12-01 2017-04-18 Samsung Electronics Co, Ltd. Method of separating target cell in biological sample
SG10201601349XA (en) 2011-12-13 2016-03-30 Engeneic Molecular Delivery Pty Ltd Bacterially derived, intact minicells for delivery of therapeutic agents to brain tumors
EP2807180B1 (en) 2012-01-24 2018-03-28 InterK Peptide Therapeutics Limited Peptide agents for cancer therapy
EA032740B1 (ru) 2013-10-04 2019-07-31 Энджинеик Молекьюлар Деливери Пти Лтд Способ лечения опухоли у индивидуума и набор для осуществления способа
US10328159B2 (en) 2014-10-03 2019-06-25 Engenic Molecular Delivery Pty Ltd. Enhanced loading of intact, bacterially derived vesicles with small molecule compounds
CN113577323B (zh) 2015-08-04 2024-02-20 瓦克星治疗有限责任公司 基于细菌小细胞的生物药物的电离辐射灭菌以及使用方法
SG11201902940RA (en) 2016-10-06 2019-05-30 Engeneic Molecular Delivery Pty Ltd Bacterial minicells for delivering nucleic acid adjuvants and methods of using the same
JP2021532106A (ja) 2018-07-23 2021-11-25 エンジーンアイシー モレキュラー デリバリー ピーティーワイ リミテッド 細菌由来ミニ細胞を含む組成物およびそれを使用する方法
US20230242867A1 (en) * 2020-06-17 2023-08-03 Flagship Pioneering Innovations Vi, Llc Methods for manufacturing adas
CN113186100B (zh) * 2021-05-11 2022-10-04 中国科学院青岛生物能源与过程研究所 一种富集污水微生物以用于单细胞精度表型测量和分选的试剂盒及方法

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4311797A (en) 1979-09-18 1982-01-19 University Of Saskatchewan Anucleated live E. coli vaccine
CA2370628A1 (en) 1999-04-21 2000-10-26 American Home Products Corporation Methods and compositions for inhibiting the function of polynucleotide sequences
US6635448B2 (en) * 2000-08-21 2003-10-21 Clonexdevelopment, Inc. Methods and compositions for increasing protein yield from a cell culture
US7125679B2 (en) * 2001-03-07 2006-10-24 Children's Medical Center Corporation Methods to screen peptide libraries using minicell display
US7011946B2 (en) * 2001-05-22 2006-03-14 Trustees Of Tufts College In vivo assay for identification of antimicrobial agents
US20030194798A1 (en) * 2001-05-24 2003-10-16 Surber Mark W. Minicell compositions and methods
ES2380612T3 (es) 2001-10-15 2012-05-16 Engeneic Molecular Delivery Pty Ltd. Minicélulas intactas como vectores para transferencia de ADN y terapia génica in vitro e in vivo
EP2272946B9 (en) 2002-02-25 2015-06-24 Vaxiion Therapeutics, LLC Minicell compositions and methods
US7611885B2 (en) * 2003-06-24 2009-11-03 Engeneic Molecular Delivery Pty, Ltd. Pharmaceutically compatible method for purifying intact bacterial minicells
EP1694361B1 (en) * 2003-12-09 2011-03-16 EnGeneIC Molecular Delivery Pty Ltd. Targeted gene delivery to non-phagocytic mammalian cells via bacterially derived intact minicells
US8772013B2 (en) * 2004-02-02 2014-07-08 Engeneic Molecular Delivery Pty Ltd Methods for targeted in vitro and in vivo drug delivery to mammalian cells via bacterially derived intact minicells
DK2386640T3 (da) * 2004-08-26 2015-04-27 Engeneic Molecular Delivery Pty Ltd Afgivelse af funktionelle nukleinsyrer til pattedyrceller via bakterielt afledte, intakte miniceller
KR100967868B1 (ko) 2004-12-17 2010-07-05 베쓰 이스라엘 디코니스 메디칼 센터 박테리아 매개 유전자 침묵을 위한 조성물 및 이것을이용하는 방법
HUE033007T2 (en) * 2006-06-23 2017-11-28 Engeneic Molecular Delivery Pty Ltd Targeted drug, therapeutic nucleic acid and functional nucleic acid delivery to mammalian cells via intact killed bacterial cells

Also Published As

Publication number Publication date
US10076545B2 (en) 2018-09-18
MXPA05013620A (es) 2006-02-24
DK1947171T3 (da) 2011-09-19
AU2004249970B2 (en) 2009-09-10
AU2004249970A1 (en) 2004-12-29
US20110177185A1 (en) 2011-07-21
EP2333044B1 (en) 2016-08-17
ATE461269T1 (de) 2010-04-15
US8449877B2 (en) 2013-05-28
CN103361286A (zh) 2013-10-23
SI2333044T1 (sl) 2016-12-30
ES2602572T3 (es) 2017-02-21
EP1636344A1 (en) 2006-03-22
CA2780843C (en) 2013-12-10
CN1809629B (zh) 2013-06-12
DK2333044T3 (da) 2016-12-12
CY1118218T1 (el) 2017-06-28
JP4834544B2 (ja) 2011-12-14
HK1089207A1 (en) 2006-11-24
PL2333044T3 (pl) 2017-02-28
US20070241067A1 (en) 2007-10-18
EP1636344A4 (en) 2006-07-19
PT2333044T (pt) 2016-11-21
JP2007520201A (ja) 2007-07-26
NZ544653A (en) 2009-02-28
DK1636344T3 (da) 2010-05-31
CA2780843A1 (en) 2012-08-13
CA2530055C (en) 2012-10-02
ES2367535T3 (es) 2011-11-04
US7611885B2 (en) 2009-11-03
CN1809629A (zh) 2006-07-26
WO2004113507A9 (en) 2006-08-24
US20040265994A1 (en) 2004-12-30
CN103361286B (zh) 2016-12-28
HK1158261A1 (zh) 2012-07-13
US20130236422A1 (en) 2013-09-12
CA2530055A1 (en) 2004-12-29
US8003091B2 (en) 2011-08-23
ES2342830T3 (es) 2010-07-15
AU2009239519A1 (en) 2009-12-10
AU2009239519B2 (en) 2010-04-22
HUE030642T2 (en) 2017-06-28
PT1947171E (pt) 2011-09-07
HK1121190A1 (en) 2009-04-17
EP1636344B1 (en) 2010-03-17
ATE513032T1 (de) 2011-07-15
WO2004113507A1 (en) 2004-12-29
EP1947171B1 (en) 2011-06-15
PL1947171T3 (pl) 2011-12-30
EP2333044A1 (en) 2011-06-15
EP1947171A1 (en) 2008-07-23

Similar Documents

Publication Publication Date Title
CY1118218T1 (el) Φαρμακευτικα συμβατη μεθοδος για τον καθαρισμο αθικτων βακτηριακων μινι-κυτταρων
Banin et al. Role of endosymbiotic zooxanthellae and coral mucus in the adhesion of the coral-bleaching pathogen Vibrio shiloi to its host
Garon et al. Structural features of Borrelia burgdorferi—the Lyme disease spirochete: silver staining for nucleic acids
JPS6391093A (ja) 高分子量dnaの迅速単離方法
DE69535120D1 (de) L-Isoleucin produzierendes Bacterium und Verfahren zur Herstellung von L-Isoleucin durch Fermentation
ATE530253T1 (de) Zusammensetzung, kit und verfahren zur zelltrennung
JP2002515508A (ja) 核酸の精製方法および装置
WO1994021782A3 (en) Dna isolation method
ES2397516T3 (es) Procedimiento de aislamiento de endotoxinas
Brown et al. Chloroplast RNA populations in dark-grown, light-grown, and greening Euglena gracilis
HUT62311A (en) Process for separating dna
ATE107171T1 (de) Verfahren zur herstellung tierärztlicher acellularer impfstoffe gegen gramnegative momenterische pathogene bazillen.
Urumbil et al. Diversity analysis of endophytic bacterial microflora in Emilia sonchifolia (Linn.) DC on Illumina Mi Seq platforms
WO2004048398A1 (ja) 核酸の濃縮精製方法および装置
Krusberg et al. Technique for axenizing nematodes
KR880701110A (ko) 생물학적 반응 모디파이어
RU2664729C1 (ru) Способ очистки сыворотки крови крупного рогатого скота от контаминирующих агентов
ATE321062T1 (de) Verfahren zur herstellung endotoxinfreier nukleinsäuren
Allen Isolation of micronuclear and macronuclear DNA
DE69012903D1 (de) Verfahren zur herstellung und reinigung von hepatitis b-impfstoff.
SHIOMI et al. Metrizamide isopycnic centrifugation for the isolation of macro-and micronuclei from Paramecium
CN118667750A (zh) 一种简单高效分离完整细胞核的方法
DE60140373D1 (de) Fermentationsverfahren zur herstellung von l-aminosäuren unter verwendung von stämmen aus der familie der enterobacteriaceae
Holmqvist Disappearence of the intracytoplasmic membranes in Rhodopseudomonas sphaeroides: A quantitative ultrastructural study
Takigami et al. 2.9 Removal of Pollutants by Mutant Strains of Microorganisms Induced by Ion-Beam Irradiation Fixation of CO2 by Microalgae

Legal Events

Date Code Title Description
8364 No opposition during term of opposition